Adcock Ingram says it has started recalling batches of Citro-Soda after an inspection by the South African Health Products Regulatory Authority Sahpra.
The pharmaceutical company said it is acting immediately to implement the required actions. This is to ensure ongoing compliance with regulatory and quality standards we are co-operating fully with Sahpra, it said, adding that the batches being recalled were ones made only at the Clayville site.
The health regulatory body said it had identified the Clayville facility in Johannesburg as having a contamination risk. Sahpra CEO Dr Boitumelo Semete-Makokotlela said an evaluation of the facilities manufacturing practices led to the regulator deciding to recall the batch.
